Core Viewpoint - Shanghai Xinyao Paike Medical Technology Co., Ltd. has successfully developed into a leading manufacturer of drug delivery devices, driven by a strong team spirit and a focus on addressing market pain points in the medical device sector [2][4][8]. Company Development - The company was founded by a team with extensive experience in the medical industry, who identified the market's reliance on foreign products and aimed to create high-end drug delivery devices for the Chinese market [4][5]. - Xinyao Paike has expanded its product offerings to include pre-filled syringes and self-injection pens, with a focus on chronic disease management [6][7]. Product Innovation - The company has achieved significant milestones in the development of needle protection devices, capturing over 90% of the domestic market share and establishing partnerships with leading pharmaceutical companies [5][8]. - Xinyao Paike's self-injection pens are designed for patients with chronic diseases, allowing for convenient at-home medication administration [7][8]. Market Strategy - The company emphasizes a market-driven approach to project selection, ensuring that all product developments are aligned with customer needs and market demands [6][8]. - Xinyao Paike has implemented a rigorous project approval process involving multiple departments to ensure the feasibility and foresight of new initiatives [8][9]. Team and Talent Development - The success of Xinyao Paike is attributed to a cohesive and collaborative founding team, which has fostered trust and efficiency in market execution [9]. - The company actively recruits talent through partnerships with educational institutions and industry networks, aiming to build a strong talent pipeline [9]. Future Outlook - Xinyao Paike plans to continue its focus on the drug delivery device sector, enhancing product quality and technology while expanding both domestic and international markets [9].
新耀湃科牛江龙:打造国产给药装置新名片
Shang Hai Zheng Quan Bao·2025-07-03 19:03